Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis

DMM Disease Models and Mechanisms

Volumn 8, Issue 9, 2015, Pages 1037-1046

  Turola, Elena ^a   Petta, Salvatore ^b   Vanni, Ester ^c   Milosa, Fabiola ^a   Valenti, Luca ^d   Critelli, Rosina ^a   Miele, Luca ^e   Maccio, Livia ^a   Calvaruso, Vincenza ^b   Fracanzani, Anna L ^d   Bianchini, Marcello ^a   Raos, Nazarena ^a   Bugianesi, Elisabetta ^c   Mercorella, Serena ^a   Di Giovanni, Marisa ^a   Craxì, Antonio ^b   Fargion, Silvia ^d   Grieco, Antonio ^e   Cammà, Calogero ^b   Cotelli, Franco ^f   Villa, Erica ^a   more..

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^e CATHOLIC UNIVERSITY   (Italy)

^f UNIVERSITY OF MILAN   (Italy)

Author keywords

Fibrosis; Menopause; Non alcoholic fatty liver disease; Ovarian senescence; Zebrafish

Indexed keywords

COLLAGEN; ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTHROPOMETRIC PARAMETERS; ARTICLE; BIOCHEMICAL ANALYSIS; BODY MASS; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE SEVERITY; FATTY LIVER; FEMALE; GENETIC ANALYSIS; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LIPID METABOLISM; LIVER BIOPSY; LIVER FIBROSIS; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; METABOLIC PARAMETERS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OVARIAN SENESCENCE; OVARY FOLLICLE; OVARY FUNCTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SENESCENCE; SEX DIFFERENCE; ZEBRA FISH; AGED; ANIMAL; ANTHROPOMETRY; BIOPSY; CELL AGING; COHORT ANALYSIS; DISEASE COURSE; LIVER CIRRHOSIS; MIDDLE AGED; ODDS RATIO; OVARY; PATHOLOGY;

ADULT; AGED; ANIMALS; ANTHROPOMETRY; BIOPSY; BODY MASS INDEX; CELL AGING; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; MENOPAUSE; MIDDLE AGED; MODELS, ANIMAL; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; OVARY; REAL-TIME POLYMERASE CHAIN REACTION; RISK FACTORS; ZEBRAFISH;

EID: 84941557063     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.019950     Document Type: Article

References (59)

1. Abdelmalek, M. F., Suzuki, A., Guy, C., Unalp-Arida, A., Colvin, R., Johnson, R. J. and Diehl, A. M. (2010). Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 51, 1961-1971.
2. Agh, N., Van Stappen, G., Bossier, P., Sepehri, H., Lotfi, V., Rouhani, S. M. R. and Sorgeloos, P. (2008). Effects of salinity on survival, growth, reproductive and life span characteristics of Artemia populations from Urmia Lake and neighboring lagoons. Pak. J. Biol. Sci. 11, 164-172.
3. American Diabetes Association (2000). Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. American Diabetes Association: Clinical Practice Recommendations 2000 Committee Report. Diabetes Care 2000 23.
4. Argo, C. K., Northup, P. G., Al-Osaimi, A. M. S. and Caldwell, S. H. (2009). Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J. Hepatol. 51, 371-379.
5. Asaoka, Y., Terai, S., Sakaida, I. and Nishina, H. (2013). The expanding role of fish models in understanding non-alcoholic fatty liver disease. Dis. Model. Mech. 6, 905-914.
6. Aytekin, Y. and Yuce, R. (2008). Ovary maturaton stages and histological investigation of ovary of the Zebrafish (Danio rerio). Braz. Arch. Biol. Technol. 51, 513-522.
7. Bayer, E. M., Herr, W., Kanzler, S., Waldmann, C., Meyer ZumBuschenfelde, K.-H., Dienes, H. P. and Lohse, A. W. (1998). Transforming growth factor-beta1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity. J. Hepatol. 28, 803-811.
8. Bedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G. and Bellentani, S. (2005). Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 42, 44-52.
9. Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M. and Hobbs, H. H. (2004). Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40, 1387-1395.
10. Buettner, R., Scholmerich, J. and Bollheimer, L. C. (2007). High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity 15, 798-808.
11. Bugianesi, E., Marchesini, G., Gentilcore, E., Cua, I. H. Y., Vanni, E., Rizzetto, M. and George, J. (2006). Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: role of insulin resistance and hepatic steatosis. Hepatology 44, 1648-1655.
12. Burcelin, R., Crivelli, V., Dacosta, A., Roy-Tirelli, A. and Thorens, B. (2002). Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet. Am. J. Physiol. Endocrinol. Metab. 282, E834-E842.
13. Calvaruso, V., Burroughs, A. K., Standish, R., Manousou, P., Grillo, F., Leandro, G., Maimone, S., Pleguezuelo, M., Xirouchakis, I., Guerrini, G. P. et al. (2009). Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient. Hepatology 49, 1236-1244.
14. Castranova, D., Lawton, A., Lawrence, C., Baumann, D. P., Best, J., Coscolla, J., Doherty, A., Ramos, J., Hakkesteeg, J., Wang, C. et al. (2011). The effect of stocking densities on reproductive performance in laboratory zebrafish (Danio rerio). Zebrafish 8, 141-146.
15. Chow, J. D. Y., Jones, M. E. E., Prelle, K., Simpson, E. R. and Boon, W. C. (2011). A selective estrogen receptor alpha agonist ameliorates hepatic steatosis in the male aromatase knockout mouse. J. Endocrinol. 210, 323-334.
16. Clark, J. M., Brancati, F. L. and Diehl, A. M. (2002). Nonalcoholic fatty liver disease. Gastroenterology 122, 1649-1657.
17. Collins, B. H., Holzknecht, Z. E., Lynn, K. A., Sempowski, G. D., Smith, C. C., Liu, S., Parker, W. and Rockey, D. C. (2013). Association of age-dependent liver injury and fibrosis with immune cell populations. Liver Int. 33, 1175-1186.
18. Colloredo, G., Guido, M., Sonzogni, A. and Leandro, G. (2003). Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J. Hepatol. 39, 239-244.
19. Dongiovanni, P., Anstee, Q. M. and Valenti, L. (2013). Genetic predisposition in NAFLD and NASH: impact on severity of liver disease and response to treatment. Curr. Pharm. Design 19, 5219-5238.
20. Erkan, G., Yilmaz, G., Konca Degertekin, C., Akyol, G. and Ozenirler, S. (2013). Presence and extent of estrogen receptor-alpha expression in patients with simple steatosis and NASH. Pathol. Res. Pract. 209, 429-432.
21. Gopalakrishnan, S., Cheung, N. K. M., Yip, B. W. P. and Au, D. W. T. (2013). Medaka fish exhibits longevity gender gap, a natural drop in estrogen and telomere shortening during aging: a unique model for studying sex-dependent longevity. Front. Zool. 10, 78.
22. Hamaguchi, M., Kojima, T., Ohbora, A., Takeda, N., Fukui, M. and Kato, T. (2012). Aging is a risk factor of nonalcoholic fatty liver disease in premenopausal women. World J. Gastroenterol. 18, 237-243.
23. Hellemans, J., Mortier, G., De Paepe, A., Speleman, F. and Vandesompele, J. (2007). qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 8, R19.
24. Hewitt, K. N., Pratis, K., Jones, M. E. E. and Simpson, E. R. (2004). Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase knockout mouse. Endocrinology 145, 1842-1848.
25. Holtta-Vuori, M., Salo, V. T. V., Nyberg, L., Brackmann, C., Enejder, A., Panula, P. and Ikonen, E. (2010). Zebrafish: gaining popularity in lipid research. Biochem. J. 429, 235-242.
26. Hsu, S. C. and Huang, C. J. (2006). Reduced fat mass in rats fed a high oleic acidrich safflower oil diet is associated with changes in expression of hepatic PPARalpha and adipose SREBP-1c-regulated genes. J. Nutr. 136, 1779-1785.
27. Ikeda, Y., Suehiro, T., Nakamura, T., Kumon, Y. and Hashimoto, K. (2001). Clinical significance of the insulin resistance index as assessed by homeostasis model assessment. Endocr. J. 48, 81-86.
28. Itagaki, T., Shimizu, I., Cheng, X., Yuan, Y., Oshio, A., Tamaki, K., Fukuno, H., Honda, H., Okamura, Y. and Ito, S. (2005). Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells. Gut 54, 1782-1789.
29. Kireev, R. A., Tresguerres, A. C. F., Garcia, C., Borras, C., Ariznavarreta, C., Vara, E., Vina, J. and Tresguerres, J. A. F. (2010). Hormonal regulation of proinflammatory and lipid peroxidation processes in liver of old ovariectomized female rats. Biogerontology 11, 229-243.
30. Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y.-C., Torbenson, M. S., Unalp-Arida, A. et al. (2005). Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313-1321.
31. Kuroda, H., Kakisaka, K., Kamiyama, N., Oikawa, T., Onodera, M., Sawara, K., Oikawa, K., Endo, R., Takikawa, Y. and Suzuki, K. (2012). Non-invasive determination of hepatic steatosis by acoustic structure quantification from ultrasound echo amplitude. World J. Gastroenterol. 18, 3889-3895.
32. Lovejoy, J. C., Champagne, C. M., de Jonge, L., Xie, H. and Smith, S. R. (2008). Increased visceral fat and decreased energy expenditure during the menopausal transition. Int. J. Obes. 32, 949-958.
33. Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N. et al. (2003). Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37, 917-923.
34. Marlow, F. L. and Mullins, M. C. (2008). Bucky ball functions in Balbiani body assembly and animal-vegetal polarity in the oocyte and follicle cell layer in zebrafish. Dev. Biol. 321, 40-50.
35. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F. and Turner, R. C. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419.
36. McKenzie, J., Fisher, B. M., Jaap, A. J., Stanley, A., Paterson, K. and Sattar, N. (2006). Effects of HRT on liver enzyme levels in women with type 2 diabetes: a randomized placebo-controlled trial. Clin. Endocrinol. 65, 40-44.
37. Oka, T., Nishimura, Y., Zang, L., Hirano, M., Shimada, Y., Wang, Z., Umemoto, N., Kuroyanagi, J., Nishimura, N. and Tanaka, T. (2010). Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity. BMC Physiol. 10, 21.
38. Park, S. H., Jeon, W. K., Kim, S. H., Kim, H. J., Park, D. I., Cho, Y. K., Sung, I. K., Sohn, C. I., Keum, D. K. and Kim, B. I. (2006). Prevalence and risk factors of nonalcoholic fatty liver disease among Korean adults. J. Gastroenterol. Hepatol. 21, 138-143.
39. Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Osterreicher, C. H., Takahashi, H. and Karin, M. (2010). Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell 140, 197-208.
40. Persson, L., Henriksson, P., Westerlund, E., Hovatta, O., Angelin, B. and Rudling, M. (2012). Endogenous estrogens lower plasma PCSK9 and LDL cholesterol but not Lp(a) or bile acid synthesis in women. Arterioscler. Thromb. Vasc. Biol. 32, 810-814.
41. Petta, S. and Craxi, A. (2010). Hepatocellular carcinoma and non-alcoholic fatty liver disease: from a clinical to a molecular association. Curr. Pharm. Design 16, 741-752.
42. Petta, S., Muratore, C. and Craxì, A. (2009). Non-alcoholic fatty liver disease pathogenesis: the present and the future. Dig. Liver Dis. 41, 615-625.
43. Petta, S., Camma, C., Cabibi, D., Di Marco, V. and Craxì, A. (2011a). Hyperuricemia is associated with histological liver damage in patients with nonalcoholic fatty liver disease. Aliment. Pharmacol. Ther. 34, 757-766.
44. Petta, S., Tripodo, C., Grimaudo, S., Cabibi, D., Camma, C., Di Cristina, A., Di Marco, V., Di Vita, G., Ingrao, S., Mazzola, A. et al. (2011b). High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis. Dig. Liver Dis. 43, 404-410.
45. Ramezani Tehrani, F., Behboudi-Gandevani, S., Ghanbarian, A. and Azizi, F. (2014). Effect of menopause on cardiovascular disease and its risk factors: a 9-year follow-up study. Climacteric 17, 164-172.
46. Rogers, A. and Eastell, R. (2001). The effect of 17beta-estradiol on production of cytokines in cultures of peripheral blood. Bone 29, 30-34.
47. SAS Institute Inc. (1992). SAS/STAT software: changes and enhancement, Release 6. 07. SAS Technical Report.
48. Schneider, C. A., Rasband, W. S. and Eliceiri, K. W. (2012). NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671-675.
49. Shao, J., Chen, D., Ye, Q., Cui, J., Li, Y. and Li, L. (2011). Tissue regeneration after injury in adult zebrafish: the regenerative potential of the caudal fin. Dev. Dyn. 240, 1271-1277.
50. Tailleux, A., Wouters, K. and Staels, B. (2012). Roles of PPARs in NAFLD: potential therapeutic targets. Biochim. Biophys. Acta 1821, 809-818.
51. Targher, G., Marra, F. and Marchesini, G. (2008). Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia 51, 1947-1953.
52. van der Poorten, D., Milner, K.-L., Hui, J., Hodge, A., Trenell, M. I., Kench, J. G., London, R., Peduto, T., Chisholm, D. J. and George, J. (2008). Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 48, 449-457.
53. Villa, E., Karampatou, A., Camma, C., Di Leo, A., Luongo, M., Ferrari, A., Petta, S., Losi, L., Taliani, G., Trande, P. et al. (2011). Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C. Gastroenterology 140, 818-829. e2.
54. Villa, E., Vukotic, R., Camma, C., Petta, S., Di Leo, A., Gitto, S., Turola, E., Karampatou, A., Losi, L., Bernabucci, V. et al. (2012). Reproductive status is associated with the severity of fibrosis in women with hepatitis C. PLoS ONE 7, e44624.
55. Volzke, H., Schwarz, S., Baumeister, S. E., Wallaschofski, H., Schwahn, C., Grabe, H. J., Kohlmann, T., John, U. and Doren, M. (2007). Menopausal status and hepatic steatosis in a general female population. Gut 56, 594-595.
56. Yang, J. D., Abdelmalek, M. F., Pang, H., Guy, C. D., Smith, A. D., Diehl, A. M. and Suzuki, A. (2014). Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis. Hepatology 59, 1406-1414.
57. Yasuda, M., Shimizu, I., Shiba, M. and Ito, S. (1999). Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats. Hepatology 29, 719-727.
58. Yu, S., Matsusue, K., Kashireddy, P., Cao, W.-Q., Yeldandi, V., Yeldandi, A. V., Rao, M. S., Gonzalez, F. J. and Reddy, J. K. (2003). Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J. Biol. Chem. 278, 498-505.
59. Zhang, C., Wang, G., Zheng, Z., Maddipati, K. R., Zhang, X., Dyson, G., Williams, P., Duncan, S. A., Kaufman, R. J. and Zhang, K. (2012). Endoplasmic reticulumtethered transcription factor cAMP responsive element-binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice. Hepatology 55, 1070-1082.